BioStem Technologies Statistics
Total Valuation
BSEM has a market cap or net worth of $143.61 million. The enterprise value is $147.32 million.
| Market Cap | 143.61M |
| Enterprise Value | 147.32M |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
BSEM has 16.23 million shares outstanding. The number of shares has increased by 78.14% in one year.
| Shares Outstanding | 16.23M |
| Shares Change (YoY) | +78.14% |
| Shares Change (QoQ) | +50.41% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 8.26 |
| PS Ratio | 2.48 |
| Forward PS | 0.92 |
| PB Ratio | 21.62 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2.54 |
| EV / EBITDA | 2,428.35 |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.13, with a Debt / Equity ratio of 0.66.
| Current Ratio | 1.13 |
| Quick Ratio | 1.09 |
| Debt / Equity | 0.66 |
| Debt / EBITDA | 71.87 |
| Debt / FCF | n/a |
| Interest Coverage | -0.22 |
Financial Efficiency
Return on equity (ROE) is -8.07% and return on invested capital (ROIC) is -1.48%.
| Return on Equity (ROE) | -8.07% |
| Return on Assets (ROA) | -1.17% |
| Return on Capital (ROIC) | -1.48% |
| Revenue Per Employee | $1.66M |
| Profits Per Employee | -$15,309 |
| Employee Count | 35 |
| Asset Turnover | 2.64 |
| Inventory Turnover | 5.43 |
Taxes
In the past 12 months, BSEM has paid $162,162 in taxes.
| Income Tax | 162,162 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +374.53% in the last 52 weeks. The beta is 1.84, so BSEM's price volatility has been higher than the market average.
| Beta (5Y) | 1.84 |
| 52-Week Price Change | +374.53% |
| 50-Day Moving Average | 8.57 |
| 200-Day Moving Average | 7.25 |
| Relative Strength Index (RSI) | 46.29 |
| Average Volume (20 Days) | 19,735 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BSEM had revenue of $58.01 million and -$535,803 in losses. Loss per share was -$0.15.
| Revenue | 58.01M |
| Gross Profit | 54.46M |
| Operating Income | -163,178 |
| Pretax Income | -535,277 |
| Net Income | -535,803 |
| EBITDA | 60,668 |
| EBIT | -163,666 |
| Loss Per Share | -$0.15 |
Balance Sheet
The company has $643,241 in cash and $4.36 million in debt, giving a net cash position of -$3.72 million or -$0.23 per share.
| Cash & Cash Equivalents | 643,241 |
| Total Debt | 4.36M |
| Net Cash | -3.72M |
| Net Cash Per Share | -$0.23 |
| Equity (Book Value) | 6.64M |
| Book Value Per Share | 0.41 |
| Working Capital | 4.93M |
Cash Flow
In the last 12 months, operating cash flow was -$2.28 million and capital expenditures -$57,582, giving a free cash flow of -$2.33 million.
| Operating Cash Flow | -2.28M |
| Capital Expenditures | -57,582 |
| Free Cash Flow | -2.33M |
| FCF Per Share | -$0.10 |
Margins
Gross margin is 93.88%, with operating and profit margins of -0.28% and -0.92%.
| Gross Margin | 93.88% |
| Operating Margin | -0.28% |
| Pretax Margin | -0.92% |
| Profit Margin | -0.92% |
| EBITDA Margin | 0.10% |
| EBIT Margin | -0.28% |
| FCF Margin | -4.02% |
Dividends & Yields
BSEM does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -78.14% |
| Shareholder Yield | -78.14% |
| Earnings Yield | -0.37% |
| FCF Yield | -1.63% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on January 27, 2015. It was a reverse split with a ratio of 1:400.
| Last Split Date | Jan 27, 2015 |
| Split Type | Reverse |
| Split Ratio | 1:400 |
Scores
BSEM has an Altman Z-Score of 2.33 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.33 |
| Piotroski F-Score | 4 |